National Asset Management, Inc. Alvotech Transaction History

National Asset Management, Inc.

  • $3.51 Billion
  • Q3 2024

A detailed history of National Asset Management, Inc. transactions in Alvotech stock. As of the latest transaction made, National Asset Management, Inc. holds 50,000 shares of ALVO stock, worth $676,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$676,000
Previous $608,000 2.14%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 01, 2023
BUY
$8.12 - $10.07 $202,999 - $251,750
25,000 Added 100.0%
50,000 $455,000
Q2 2023

Jul 27, 2023
BUY
$6.9 - $13.85 $172,500 - $346,250
25,000 New
25,000 $193,000

Others Institutions Holding ALVO

# of Institutions
32
Shares Held
15.5M
Call Options Held
0
Put Options Held
0
View Full List

About Alvotech

ALVO Quotes by TradingView
  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.36B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email